Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland, United States
Dr. Michail Lionakis is a physician-scientist and Head of the Fungal Pathogenesis Section in NIAID’s Laboratory of Clinical Immunology and Microbiology where he is Deputy Chief. He obtained his MD and ScD from the University of Crete, Greece. He did postdoctoral research training at MD Anderson Cancer Center, followed by Internal Medicine Residency at Baylor College of Medicine, and Infectious Disease Fellowship at NIAID/NIH. He established his laboratory in 2012 at NIAID and received tenure in 2017. Dr. Lionakis' laboratory bench-to-bedside research focuses on 1) better understanding the genetic and immune defects that underlie susceptibility to fungal infections in humans and on 2) cellular and molecular factors that regulate the immune response against fungi in clinically relevant animal models. His work has defined precise genetic, biochemical, immunologic, and cellular disease mechanisms that have led to targeted immunotherapies. Dr. Lionakis' lab has published papers in journals such as Science, Science Translational Medicine, Science Immunology, Nature Immunology, JCI, Journal of Experimental Medicine, Cell Host Microbe, and Cancer Cell. He is elected in the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP), and is a Fellow of the American Academy of Microbiology (AAM) and the American Association for the Advancement of Science (AAAS). He has received several awards including the NIH Director’s award, the Infectious Diseases Society of America Oswald Avery Award for Early Achievement, the Junior Investigator Award from the Immunocompromised Host Society, and the American College of Physicians Walter J. McDonald Award for Early Career Physicians.
Disclosure information not submitted.
APS-1/APECED: Mechanisms & Treatment of Autoimmunity
Friday, June 21, 2024
10:30 AM – 11:00 AM PT
